An study to assess blood cytokine levels in patients having leprosy and leprosy reactions.
Not Applicable
- Conditions
- Health Condition 1: A30- Leprosy [Hansens disease]
- Registration Number
- CTRI/2020/09/027920
- Lead Sponsor
- DR RITUL CHOUDHARY
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Untreated Adult ( > 18 yrs) leprosy patients with lepra reaction.
2.Untreated Adult ( > 18 yrs) leprosy patients without lepra reaction.
Exclusion Criteria
1.Patients below 18 years of age.
2.Patients who have received Multi Drug therapy for leprosy.
3.Pregnant and lactating women.
4.Patients with Severe anaemia.
5.Chronic infections such as tuberculosis, HIV and helminthic infestation and autoimmune diseases.
6.Patient who will not consent for sampling.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison of serum Levels of IL-17 and IL-9 in leprosy patients with lepra reaction with leprosy patient without reaction.Timepoint: At end of study.
- Secondary Outcome Measures
Name Time Method To compare the levels IL-17 and IL-9 in type 1 lepra reaction vs type 2 lepra reaction.Timepoint: At end of study.